PainSci Member Login
Submit your email to unlock this audio content (and any other stuff for members). If you can’t remember or access your registration email, please contact me. ~ Paul Ingraham, PainSci Publisher
Found! 🙂 Member content on this page only has just been unlocked. To unlock member content on all other pages for a month, see the confirmation email just sent. (If it doesn’t turn up in your inbox, check your spam folder! Email can also sometimes take a few minutes. If it never turns up, just contact me.)
Found! But… You have a PainSci account, but this content cannot be unlocked, because you do not have an active PainSci membership with perks for that. You may have have a basic membership and/or access to books only. For more information, see your account page or confirmation email (just sent).
Not found! 🙁 Sorry, but that email address is not in the PainSci database.
⚠️ Sorry, too many lookups right now. This is a rare error. It should go away if you try again in a little bit.
Privacy & Security of this form This login is private and secure: the information you submit is encrypted, used only to search for matching accounts, and then discarded.
“Paxlovid rebound” is the idea that taking the anti-viral medication Paxlovid will help with a Covid infection initially, but then — ruh roh — things get worse after a week or so. Nope! That’s just Covid being Covid. Paxlovid rebound was never a thing, still is not a thing, and never will be a thing: people are simply blaming the wrong thing.
I’m paraphrasing Dr. Daniel Griffin, who has immense experience treating COVID patients. In his own words:
“Let’s stop with this misinformation. Let’s call this what we called it early on: it’s the second week, it’s the period of the cytokine storm, the hypoxic phase… no ‘rebound’ here.”
As always when I bring up Covid, it’s because long Covid hurts: pain is a common long-term symptom of Covid (see Ebbesen and Cui), and long Covid is common and can occur even after mild cases (but much more so after nasty ones). Vaccination and Paxlovid both reduce the severity of Covid, and therefore the risk of long Covid, and new cases of chronic pain.
Ebbesen et al. was just published, so that’s today’s pain science update. They report some super depressing news in this paper, strongly underlining the “Covid hurts” thing: at least 5% of 130,000 people who had mild Covid (not hospitalized) developed new widespread musculoskeletal pain after their infections … and still had it more than a year later. Ugh. ☹️
That is a lot of hurting: at least 6500 people in that study group all got an ugly, long-term legacy from their Covid infections … and without even going through the deadly wringer of hospitalization. If that’s what mild Covid can do, I shudder to think what severe Covid can do. (Unfortunately, we know exactly what it can do now, and it is indeed shudder-inducing: see Davis et al, also new. They went into freaky detail about the incredible list of post-Covid complications. Full text and tables.)
It will never really be “over” — especially for the people with long Covid.